Valuation: MDxHealth SA

Market Cap 13.95M 15.58M 12.84M 11.63M 21.74M 1.48B 22.15M 153M 61.45M 778M 58.48M 57.23M 2.45B P/E 2026 *
-0.32x
P/E 2027 * -0.57x
Enterprise Value 135M 150M 124M 112M 210M 14.28B 214M 1.48B 593M 7.51B 564M 552M 23.69B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.38x
Free-Float
77.86%
Yield 2026 *
-
Yield 2027 * -
1 day-9.88%
1 week-10.91%
Current month-72.07%
1 month-72.07%
3 months-59.95%
6 months-92.00%
Current year-95.43%
1 week 0.16
Extreme 0.1588
0.21
1 month 0.16
Extreme 0.1588
0.68
Current year 0.16
Extreme 0.1588
4.34
1 year 0.16
Extreme 0.1588
4.92
3 years 0.16
Extreme 0.1588
5.33
5 years 0
Extreme 1.0E-5
14.3
10 years 0
Extreme 1.0E-5
61.5
Manager TitleAgeSince
Chief Executive Officer 64 18/02/2019
Director of Finance/CFO 52 22/07/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/11/2017
Chairman 58 01/01/2018
Director/Board Member 64 18/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26
MVM Partners LLC
BuyCompany 2,202,643 2.3084%
01/06/26 Free

Chairman

10,000 0.0195%
01/06/26 Free

Chief Executive Officer

942,200 1.8343%
Change 5-day change 1-year change 3-year change Capi.($)
-9.88%-10.91%-96.65%-93.47% 15.58M
-0.62%-1.87%+46.31%+56.99% 63.77B
+0.35%+3.20%+14.92%+84.55% 56.37B
+0.53%+1.96%+15.37%+106.81% 54.62B
-2.81%-4.31%+23.50%+50.90% 44.06B
-0.33%-1.93%+20.15%+98.45% 42.11B
+0.55%+2.31%+224.97%+942.56% 41B
+3.27%+47.96%+112.67%+96.48% 34.92B
+1.22%-1.44%+14.89%+47.15% 32.82B
+0.89%+20.55%-42.03%+373.03% 24.7B
Average -0.68%+5.69%+33.41%+176.34% 39.44B
Weighted average by Cap. +0.18%+5.44%+48.50%+186.12%

Financials

2026 *2027 *
Net sales 97.69M 109M 89.86M 81.42M 152M 10.36B 155M 1.07B 430M 5.45B 409M 401M 17.18B 111M 124M 102M 92.3M 173M 11.74B 176M 1.21B 488M 6.18B 464M 454M 19.48B
Net income -30.05M -33.56M -27.64M -25.05M -46.82M -3.19B -47.7M -330M -132M -1.68B -126M -123M -5.29B -18.36M -20.5M -16.88M -15.3M -28.6M -1.95B -29.13M -201M -80.83M -1.02B -76.92M -75.28M -3.23B
Net Debt 121M 135M 111M 101M 188M 12.8B 192M 1.32B 532M 6.73B 506M 495M 21.24B 139M 155M 128M 116M 216M 14.7B 220M 1.52B 611M 7.73B 581M 569M 24.39B
Projected Income Statement - Annual - MDxHealth SA
Logo MDxHealth SA
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Employees
364
Date Price Change Volume
30/10/26 $0.1633 -9.88% 1,575,342
29/10/26 $0.1812 -5.63% 443,088
28/10/26 $0.1920 -2.54% 1,544,498
27/10/26 $0.1970 +1.18% 543,096
26/10/26 $0.1947 +6.22% 915,868
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - MDxHealth SA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
0.1633USD
Average target price
0.8333USD
Spread / Average Target
+410.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MDxHealth SA
  1. Stock Market
  2. Stocks
  3. MDXH Stock